September 3, 2024
Now available VABYSMO® Prefilled Syringe
VABYSMO® (faricimab-svoa) injection, for intravitreal use, is a vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2) inhibitor indicated for the treatment of patients with:
- Neovascular (Wet) Age-Related Macular Degeneration (nAMD)
- Diabetic Macular Edema (DME)
- Macular Edema Following Retinal Vein Occlusion (RVO)